We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
-18.84%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$189M
AUM Growth
-$35.6M
Cap. Flow
+$958K
Cap. Flow %
0.51%
Top 10 Hldgs %
53.49%
Holding
84
New
11
Increased
22
Reduced
15
Closed
36

Top Buys

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$9.77M
2
IIN
IntriCon Corporation
IIN
+$8.08M
3
AGN
Allergan plc
AGN
+$6.65M
4
EHC icon
Encompass Health
EHC
+$6.1M
5
MDRX
Veradigm Inc. Common Stock
MDRX
+$5.74M

Top Sells

Rank Stock Value
1
TVTY
Tivity Health, Inc. Common Stock
TVTY
+$9.99M
2
SHPG
Shire pic
SHPG
+$7.7M
3
ABT icon
Abbott
ABT
+$5.78M
4
MRK icon
Merck
MRK
+$5.68M
5
BAX icon
Baxter International
BAX
+$5.26M

Sector Composition

Rank Sector Weight
1 Healthcare 91.46%
2 Industrials 3.75%
3 Technology 3.46%
4 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADVM
51
DELISTED
Adverum Biotechnologies
ADVM
– –
-16,884
Closed -$1.02M
AKTX
52
Akari Therapeutics
AKTX
$12.9M
– –
-205
Closed -$419K
BAX icon
53
Baxter International
BAX
$14.5B
– –
-68,190
Closed -$5.26M
BDX icon
54
Becton Dickinson
BDX
$46.9B
– –
-2,640
Closed -$672K
CLSD
55
DELISTED
Clearside Biomedical
CLSD
– –
-6,284
Closed -$580K
DGX icon
56
Quest Diagnostics
DGX
$25.6B
– –
-19,673
Closed -$2.12M
DHR icon
57
Danaher
DHR
$139B
– –
-22,502
Closed -$2.17M
ELV icon
58
Elevance Health
ELV
$83B
– –
-17,008
Closed -$4.66M
EW icon
59
Edwards Lifesciences
EW
$51.1B
– –
-11,418
Closed -$663K
FATE icon
60
Fate Therapeutics
FATE
$291M
– –
-204,333
Closed -$3.33M
GILD icon
61
Gilead Sciences
GILD
$163B
– –
-10,315
Closed -$796K
JAZZ icon
62
Jazz Pharmaceuticals
JAZZ
$15.8B
– –
-3,674
Closed -$618K
LIVN icon
63
LivaNova
LIVN
$4.53B
– –
-3,703
Closed -$459K
MD icon
64
Pediatrix Medical
MD
$2.16B
– –
-20,959
Closed -$978K
MGNX icon
65
MacroGenics
MGNX
$243M
– –
-39,456
Closed -$846K
MRK icon
66
Merck
MRK
$316B
– –
-83,937
Closed -$5.68M
OCGN icon
67
Ocugen
OCGN
$423M
– –
-666
Closed -$22K
OFIX icon
68
Orthofix Medical
OFIX
$496M
– –
-11,478
Closed -$664K
PBYI icon
69
Puma Biotechnology
PBYI
$391M
– –
-25,081
Closed -$1.15M
PFE icon
70
Pfizer
PFE
$143B
– –
-97,379
Closed -$4.07M
SGMO
71
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
– –
-54,523
Closed -$924K
WBA
72
DELISTED
Walgreens Boots Alliance
WBA
– –
-3,581
Closed -$261K
IMGN
73
DELISTED
Immunogen Inc
IMGN
– –
-64,065
Closed -$607K
SPPI
74
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
– –
-26,534
Closed -$446K
VRAY
75
DELISTED
ViewRay, Inc.
VRAY
– –
-75,971
Closed -$711K
1 2
3
4

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return

Endurant Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Endurant Capital Management held 84 positions worth $189M, down 16% from $225M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Endurant Capital Management's Q4 2018 filing shows 11 new, 22 increased, 15 reduced and 36 closed positions. Its largest new stake was Encompass Health: 107,187 shares worth $5.26M. The largest sale was Tivity Health, Inc. Common Stock, an estimated $9.99M.

By sector, the portfolio is most concentrated in Healthcare at 91% of assets, down from 93% a quarter earlier, followed by Industrials and Technology.

  • Endurant Capital Management's largest Q4 2018 buy was Encompass Health: 107,187 shares worth $5.26M.
  • Endurant Capital Management added most to Zimmer Biomet in Q4 2018, an estimated $9.77M increase.
  • Endurant Capital Management's biggest Q4 2018 reduction was Shire pic, cutting an estimated $7.7M.
  • Endurant Capital Management fully exited Tivity Health, Inc. Common Stock in Q4 2018, selling an estimated $9.99M.
  • Endurant Capital Management's ten largest holdings make up 53% of its $189M portfolio in Q4 2018.
  • Endurant Capital Management opened 11 new positions and closed 36 in Q4 2018.
  • Endurant Capital Management's portfolio value fell 16% quarter-over-quarter to $189M.

Based on Endurant Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.